Loading organizations...
§ Private Profile · San Antonio, TX, USA
Medical device company developing the Angel Catheter, combining a central venous catheter with an IVC filter for pulmonary embolism prevention.
Based in San Antonio, Texas, BiO2 Medical is a medical device manufacturer that develops pulmonary embolism protection and central venous access technologies for critically ill patients. The company's flagship product, the Angel Catheter, combines a standard central venous catheter with a retrievable inferior vena cava filter to trap blood clots before they reach the lungs. The enterprise has raised over $30 million in total venture funding, including a $16 million Series B and a $12 million Series C round, backed by investors such as Targeted Technology Fund and Perez Capital. The device received CE Mark approval for commercial distribution in the European Union in 2012 and subsequently obtained clearance from the FDA in 2016 following a 182-patient pivotal trial. BiO2 Medical was originally founded in 2006 by inventors Christopher E. Banas and Paul Castella.
Bi02 Medical has raised $46.7M across 5 funding rounds.
Bi02 Medical has raised $46.7M in total across 5 funding rounds.
Bi02 Medical has raised $46.7M across 5 funding rounds. Most recently, it raised $3.0M Debt in August 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 30, 2016 | $3M Debt Financing | Oxford Finance | — | Announced |
| Jan 7, 2016 | $14M Debt Financing | — | Oxford Finance | Announced |
| Jul 10, 2015 | $4M Venture Round | — | — | Announced |
| Sep 8, 2012 | $12M Series C | Remeditex Ventures | — | Announced |
| Mar 27, 2012 | $13.7M Series B | Pasadera Capital, Targeted Technology Fund | State OF Texas | Announced |
Bi02 Medical has raised $46.7M in total across 5 funding rounds.
Bi02 Medical's investors include Oxford Finance, Remeditex Ventures, Pasadera Capital, Targeted Technology Fund, State of Texas.